United-Guardian, Inc. reported a significant decline in financial performance for the third quarter and the first nine months of 2025, as detailed in its latest 10-Q filing. For the three months ended September 30, 2025, net sales totaled $2.26 million, a decrease of 26% from $3.06 million in the same period of 2024. The nine-month figures also reflected a 22% drop, with sales of $7.58 million compared to $9.71 million in the prior year. The decline was primarily attributed to a substantial decrease in sales of cosmetic ingredients, particularly to key distributor Ashland Specialty Ingredients (ASI), which faced challenges due to softer economic conditions in China and ongoing tariff issues.
The company's cost of sales as a percentage of total sales increased to 58% in the third quarter of 2025, up from 46% in the same quarter of 2024. This rise was linked to a higher proportion of pharmaceutical sales, which typically carry lower margins, and increased overhead costs due to reduced production of cosmetic products. Operating expenses also rose, increasing by 5% in the third quarter and 10% for the nine-month period, driven by higher sales and marketing costs, as well as increased payroll expenses.
In terms of strategic developments, United-Guardian entered a distribution agreement with Brenntag Specialties in October 2023 to market its new Natrajel line of sexual wellness ingredients across several regions, including North and South America. However, the launch of this product line has been delayed until 2026 due to customer timelines. The company also expanded its relationship with Azelis Group NV to include medical products in the UK and Ireland, and added South Korea as a new territory for personal care products.
The company’s balance sheet showed a decrease in total assets from $13.80 million at the end of 2024 to $12.18 million by September 30, 2025. Cash and cash equivalents also fell significantly, from $1.88 million to $860,836. Despite these challenges, United-Guardian maintains a strong current ratio of 7.0 to 1, indicating sufficient liquidity to meet its short-term obligations. Looking ahead, the company expects to continue monitoring its supply chain and exploring growth opportunities while managing the impacts of tariffs and global economic conditions on its operations.
About UNITED GUARDIAN INC
United-Guardian, Inc. specializes in manufacturing and developing specialty cosmetic ingredients, pharmaceuticals, medical lubricants, and sexual wellness products. The company focuses on innovative, environmentally friendly formulations, serving global markets through distributor partnerships. Its core value lies in product innovation, quality, and reliability, with a business model centered on research, proprietary formulations, and strategic distribution to healthcare, personal care, and sexual wellness sectors.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.